New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
07:17 EDTHZNPHorizon Pharma price target raised to $25 from $18 at Stifel
Stifel increased its price target on Horizon as the firm thinks that the company's acquisition of Vidara has left it in "ideal position" to become profitable and meet its revenue and EBITDA guidance. The firm thinks the company's drug portfolio is poised to perform well, and keeps a Buy rating on the shares.
News For HZNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 21, 2015
10:01 EDTHZNPOn the Fly: Analyst Initiation Summary
Subscribe for More Information
06:08 EDTHZNPHorizon Pharma initiated with a Buy at Citigroup
Subscribe for More Information
January 15, 2015
10:00 EDTHZNPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:14 EDTHZNPHorizon Pharma initiated with a Buy at UBS
Subscribe for More Information
January 12, 2015
08:22 EDTHZNPHorizon Pharma secures agreement with FDA on ACTIMMUNE primary endpoint
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use